Insider Trading March 27, 2026

Zevia CFO Sells Shares to Cover RSU Taxes as Company Reports Mixed Quarter

Satya Girish disposes of 41,662 Class A shares; company posts revenue shortfall but beats adjusted EBITDA estimates and inks celebrity partnership

By Maya Rios ZVIA
Zevia CFO Sells Shares to Cover RSU Taxes as Company Reports Mixed Quarter
ZVIA

Zevia PBC Chief Financial Officer Satya Girish sold 41,662 shares of Class A Common Stock on March 25, 2026 to satisfy tax obligations tied to restricted stock units, while the company reported mixed fourth-quarter 2025 results and announced a multi-year partnership with artist Cardi B. The insider sale occurred as the stock traded near its 52-week low; a subsequent RSU grant increased Girish's holdings via zero-value issuances that vest quarterly beginning March 26, 2026.

Key Points

  • Zevia CFO Satya Girish sold 41,662 Class A shares on March 25, 2026 to cover tax obligations from RSU settlements, yielding $49,136.
  • Girish directly owns 327,909 shares after the sale and was granted 453,901 RSUs on March 26, 2026 with a reported value of $0; those RSUs vest quarterly beginning March 26, 2026.
  • Zevia's Q4 2025 results showed EPS of -$0.02 in line with expectations, revenue of $37.9 million versus $40.36 million expected, and adjusted EBITDA of $0.9 million exceeding a forecasted -$0.7 million; Telsey lowered its price target from $6.00 to $5.00 but kept an Outperform rating.

Zevia PBC (NASDAQ:ZVIA) reported an insider sale and an RSU grant in late March 2026 as the company dealt with mixed financial results and a high-profile marketing arrangement.

According to a Form 4 filed with the Securities and Exchange Commission, Chief Financial Officer Satya Girish sold 41,662 shares of Class A Common Stock on March 25, 2026. The shares traded between $1.17 and $1.23, producing aggregate proceeds of $49,136. The filing states the disposition was executed to cover tax obligations associated with the settlement of restricted stock units.

The sale took place while Zevia's stock was trading close to its 52-week low of $1.11; shares were at $1.13 at the time referenced in the filing. After the transaction, Girish directly owned 327,909 shares of Zevia PBC.

On the following day, March 26, 2026, Girish received 453,901 shares of Class A Common Stock with a reported value of $0. Those shares were issued as restricted stock units under Zevia's 2021 Equity Incentive Plan. Per the filing, the RSUs vest in quarterly installments beginning March 26, 2026.


Financial results released for the fourth quarter of 2025 showed an EPS of -$0.02, which matched expectations. Revenue for the period came in at $37.9 million, below the anticipated $40.36 million, representing a 6.1% shortfall versus forecasts. Despite the revenue miss, Zevia reported adjusted EBITDA of $0.9 million, outpacing a forecasted negative $0.7 million.

Following the earnings release, Telsey Advisory Group adjusted its price target on Zevia from $6.00 to $5.00 but retained an Outperform rating. Separately, Zevia publicized a multi-year partnership with rapper Cardi B. The agreement names Cardi B as a shareholder and brand ambassador and includes Zevia sponsoring the Little Miss Drama Tour, which began in Palm Desert, California.


Market commentary included in a Pro Research Report for ZVIA noted that the stock appears undervalued at the then-current levels and that a relative strength index suggested oversold conditions. That analysis was cited as one of several insights available in the comprehensive Pro Research Report for ZVIA.

The filings and company disclosures reflect simultaneous actions on compensation and liquidity management by an executive, along with the company's public-facing marketing initiatives and quarterly performance metrics.

Risks

  • Revenue came in 6.1% below expectations, indicating potential top-line pressure that could affect beverage and consumer sectors.
  • The company’s share price trading near its 52-week low suggests continued market sensitivity to Zevia’s operating results and outlook.
  • Executive share sales to cover tax obligations related to RSUs may be viewed by some investors as liquidity-driven, which could factor into investor sentiment in the broader equities market.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026